Product Name |
Clindamycin Myristate |
Alternate Names |
Clindamycin Impurities, Impurities of Clindamycin |
CAT No. |
CS-T-51190
|
CAS No. |
Not Available |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
Not Available |
Mol. For. |
Not Available
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Clindamycin |
Smileys |
CS[C@@H]1[C@H](OC(CCCCCCCCCCCCC)=O)[C@@H](O)[C@@H](O)[C@@H]([C@@H]([C@H](Cl)C)NC([C@H]2N(C)C[C@@H](CCC)C2)=O)O1 |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Clindamycin Myristate is a type of antibiotic medication that is used to treat various bacterial infections. It is a semisynthetic derivative of lincomycin, and it belongs to the lincosamide class of antibiotics. Clindamycin Myristate is formulated to be taken orally in the form of capsules, and it is also available as an injectable solution for intravenous use.
The mechanism of action of Clindamycin Myristate involves the inhibition of bacterial protein synthesis. Specifically, it binds to the 50S ribosomal subunit of the bacterial cell and prevents the elongation of protein chains. This results in the inhibition of bacterial growth and the eventual death of the bacteria.
Clindamycin Myristate is commonly used to treat infections caused by gram-positive bacteria, such as Streptococcus, Staphylococcus, and Clostridium species. It is also effective against certain gram-negative bacteria, such as Bacteroides fragilis.
Like all medications, Clindamycin Myristate has potential side effects. The most common side effects include gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. Rarely, it may cause severe allergic reactions or the overgrowth of resistant bacteria.
In conclusion, Clindamycin Myristate is an important antibiotic medication that is widely used to treat bacterial infections. Its mechanism of action involves the inhibition of bacterial protein synthesis, and it is effective against a range of gram-positive and some gram-negative bacteria. It is important to use Clindamycin Myristate as directed by a healthcare provider to minimize the risk of adverse side effects.